The cell culture sampling devices market is anticipated to flourish at a steady CAGR of 10.8% between 2023 and 2033. The market is expected to hold a market share of USD 7.80 billion by 2033, while the market is likely to reach a value of USD 2.79 billion in 2023.
| Attributes | Details |
|---|---|
| Cell Culture Sampling Devices Market CAGR (2023 to 2033) | 10.8% |
| Cell Culture Sampling Devices Market Size (2023) | USD 2.79 billion |
| Cell Culture Sampling Devices Market Size (2033) | USD 7.80 billion |
The demand for cell culture sampling devices is likely to increase due to being widely used in the biopharmaceutical industry during the forecast period. Moreover, cell culture sampling devices provide suitable conditions or environments in which microorganisms can grow efficiently and produce a target product.
In the cell culture process, the prokaryotic cell is developed in ex-vivo conditions where cell culture sampling devices provide an artificial habitat in an under-regulated lab environment. Due to its widespread use in laboratories, the sales of cell culture sampling devices are likely to rise in recent years.
Cell culture helps the researcher in the production of medicinal drugs, biomolecules, and research studies and is believed to be one of the most important scientific equipment in the niche it serves. Moreover, cell biomass and metabolites are the key product produced via cell culture sampling devices. The metabolites perform activities like fuel, signaling, stimulatory, and other effects on enzymes, ultimately increasing the catalytic activity. This is anticipated to boost the cell culture sampling devices market in the coming period.
The technological advancement in the field helps various industries to produce their product on a large scale over conventional cell culture sampling devices. This advanced technology is likely to increase the application of cell culture sampling devices during the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The cell culture sampling devices can stimulate the growth of the mechanized large-scale cell culture with purity and high efficiency. This is expected to increase the demand for cell culture sampling devices over the forecast period.
The cell culture sampling devices market share is likely to increase in various industries, including the biopharmaceutical industry, clinic research, laboratory, and research & development activities. The strategic collaboration between manufacturers and researchers and market consolidation is likely to increase the demand for these devices. Fewer chances of contamination, improved system flexibility, and reduction in cleaning steps are further fueling their sales.
However, high maintenance with a requirement for huge capital investment to establish a cell culture research lab might put some restraints on the sales of cell culture sampling devices. In addition, the lack of highly skilled professionals can pose further challenges to the cell culture sampling devices market all around the region during the forecast period.
| Countries | Revenue Share % (2022) |
|---|---|
| United States | 36.2% |
| Germany | 8.9% |
| Japan | 2.8% |
| North America | 39.6% |
| Europe | 33.1% |
| Countries | CAGR % (2023 to 2033) |
|---|---|
| China | 11.4% |
| India | 10.4% |
| United Kingdom | 8.9% |
| Australia | 9.3% |
North America is likely to continue to dominate the global cell culture sampling devices market share attributed to the growth in research laboratories and increasing demand for biologic drugs.
Furthermore, the newly developed technology in cell culture sampling devices is also expected to result in higher demand. Thus, North America held a 39.6% market share in 2022, and during the forecast period as well, the region is expected to display formidable growth.
Government investments in the healthcare sector are anticipated to increase the market share in Europe. In addition, Europe is a hotspot for technological advancements. The presence of technologically advanced healthcare sectors, especially in the United Kingdom, is accelerating market growth.
The efficient operating cost of industries and laboratories is another factor contributing to the sales of cell culture sampling devices. Thus, Europe possessed a 33.1% market share of the cell culture sampling devices market in 2022.
Principal Consultant
| Category | By Application Type |
|---|---|
| Leading Segment | Biopharmaceuticals |
| Market Share (2022) | 31.3% |
| Category | By End User |
|---|---|
| Leading Segment | Biopharmaceutical Companies |
| Market Share (2022) | 57.8% |
The cell culture sampling devices start-ups are innovating various sampling devices which are easy to use in research labs and institutions. They are developing tools with highly advanced technology for quick results in the study of molecular biology, metabolic studies, and others, thus creating a robust cell culture sampling devices market.
The higher involvement of these start-ups may likely open new ways to adopt the existing sampling devices, as a result of which the demand for cell culture sampling devices might surge in the coming times.
Some key start-ups in the cell culture sampling device market are Allogene Therapeutics, TreeFrog Therapeutics, BlueRock Therapeutics, Regeneron, and Membio.
Membio, a Canadian start-up, offers sampling devices that enable unlimited production in a sustainable and scalable way and carry out the activities efficiently pertaining to cell culture sampling.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The cell culture sampling devices market is fragmented by the several key vendors present in the market to lift the market share of cell culture sampling devices. These players are using various tactics to acquire the lion's market share in recent years. Some popular marketing methods key players adopt are mergers, collaborations, partnerships, product launches, acquisitions, and others during the forecast period.
Recent Developments
Key Players
The market is expected to be valued at USD 2.7 billion in 2033.
Thermo Fisher Scientific and Merck & Co. Inc. are key market players.
The United States generated a 36.2% revenue in 2022.
Growing demand from the biopharmaceutical industry to boost the market prospects.
China to expand at a CAGR of 11.4% through 2033.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Device 5.1. Sampling Systems 5.2. Incubators 5.3. Sterilizer 5.4. Centrifuges 5.5. Pipetting Instruments 5.6. Biosafety Equipment 5.7. Cryostorage Equipment 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Cancer Research 6.2. Gene Therapy 6.3. Drug Development 6.4. Biopharmaceuticals 6.5. Other Applications 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Biopharmaceuticals Industry 7.2. Academic Institutes 7.3. Research Laboratories 7.4. Clinical Research Organizations 7.5. Hospitals 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Thermo Fisher Scientific 18.2. Merck & Co. Inc. 18.3. Sartorius Stedim Biotech SA 18.4. Biosan 18.5. GE Healthcare 18.6. Nova Biomedical© 18.7. Sigma-Aldrich Co., LLC 18.8. Dickinson & Company 18.9. Lonza 18.10. Corning 18.11. Eppendorf 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Cell Culture Sampling Devices Market
